Sun Pharma Advanced Research Board Meeting on Aug 10, 2026

Sun Pharma Advanced Research Company Ltd has announced that its Board of Directors will convene on August 10, 2026. The primary agenda for this meeting is to consider and approve the unaudited standalone and consolidated financial results for the quarter ending June 30, 2026. Concurrently, the company has informed about the closure of the trading window for its directors, KMPs, designated employees, and connected persons. This closure will be effective from July 1, 2026, and will remain in effect for 48 hours after the financial results are officially declared and submitted to the stock exchanges, in compliance with SEBI regulations.